Creative Planning’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-5,970
| Closed | -$405K | – | 2166 |
|
|
2019
Q3 | $405K | Buy |
+5,970
| New | +$410K | ﹤0.01% | 1192 |
|
|
2017
Q3 | – | Sell |
-100
| Closed | -$3K | – | 4265 |
|
|
2017
Q2 | $3K | Hold |
100
| – | – | ﹤0.01% | 4243 |
|
|
2017
Q1 | $3K | Sell |
100
-500
| -83% | -$14.8K | ﹤0.01% | 4222 |
|
|
2016
Q4 | $18K | Sell |
600
-31
| -5% | -$945 | ﹤0.01% | 3157 |
|
|
2016
Q3 | $18K | Buy |
631
+531
| +531% | +$14.8K | ﹤0.01% | 3142 |
|
|
2016
Q2 | $3K | Hold |
100
| – | – | ﹤0.01% | 3943 |
|
|
2016
Q1 | $2K | Buy |
+100
| New | +$2.74K | ﹤0.01% | 4027 |
|
|
2015
Q2 | – | Sell |
-1,400
| Closed | -$43K | – | 3512 |
|
|
2015
Q1 | $43K | Hold |
1,400
| – | – | ﹤0.01% | 2127 |
|
|
2014
Q4 | $45K | Sell |
1,400
-250
| -15% | -$8.14K | ﹤0.01% | 2083 |
|
|
2014
Q3 | $47K | Buy |
1,650
+250
| +18% | +$6.97K | ﹤0.01% | 1967 |
|
|
2014
Q2 | $38K | Hold |
1,400
| – | – | ﹤0.01% | 2070 |
|
|
2014
Q1 | $37K | Buy |
1,400
+700
| +100% | +$20.1K | ﹤0.01% | 1997 |
|
|
2013
Q4 | $20K | Hold |
700
| – | – | ﹤0.01% | 2199 |
|
|
2013
Q3 | $21K | Hold |
700
| – | – | ﹤0.01% | 2080 |
|
|
2013
Q2 | $22K | Buy |
+700
| New | +$23K | ﹤0.01% | 1886 |
|
Creative Planning's GHDX Position: Q4 2019 in Review
Creative Planning sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 5,970 shares — an estimated $405K sold.
Creative Planning first reported a position in GHDX in Q2 2013 and held it in 15 quarters. The position peaked at $405K in Q3 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.
- Creative Planning reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
- Creative Planning sold 5,970 Genomic Health, Inc. shares in Q4 2019, an estimated $405K.
- Creative Planning first reported a position in Genomic Health, Inc. in Q2 2013 and held it in 15 quarters.
- Creative Planning's Genomic Health, Inc. position peaked at $405K in Q3 2019.
- 0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.
Based on Creative Planning's 13F filing for Q4 2019, filed 30 Jan 2020.